Average Insider

Where insiders trade, we follow

Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ€“ Chief Medical Officer
Apr 6, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$4.06
Current$13.6147.3% above low, 52.7% below high
Purchase$12.6542.5% above low, 57.5% below high
52W High$24.27
Shares
3,970
Price
$12.65
Total Value
$50,220.50

Nearby Earnings

Mar 23, 2026
EPS:-1.02 (est: -1.46)-29.8%
Revenue:-$209.00K

Transaction Details

InsiderDoyle Mittie
TitleChief Medical Officer
Transaction DateApr 6, 2026
Transaction CodeM Exercise/Conversion
Acquired/DisposedAcquired
Security
Common Stock
Direct/IndirectDirect
Filing DateApr 8, 2026
Shares Purchased3,970
Price per Share$12.65
Total Value$50,220.50
Shares Owned After7,592
DerivativeNo
Accession Number0001918845-26-000008
DocumentView SEC Filing
Version: v26.5.2